Thiago Trovati Maciel

Title: Thiago Trovati Maciel: Innovator in Sickle Cell Disease Treatment

Introduction

Thiago Trovati Maciel is a notable inventor based in Villeneuve-le-Roi, France. He has made significant contributions to the field of medicine, particularly in the treatment of sickle cell disease. His innovative work has led to the development of a unique pharmaceutical compound aimed at improving the lives of patients suffering from this condition.

Latest Patents

Thiago Trovati Maciel holds a patent for Masitinib, which is a 2-aminoarylthiazole derivative or a pharmaceutically acceptable salt or solvate thereof. This invention is specifically designed for the treatment of sickle cell disease in patients who are in need of such intervention. Additionally, the patent covers the use of Masitinib for the prevention and/or treatment of acute chest syndrome (ACS) in sickle cell disease patients.

Career Highlights

Throughout his career, Thiago has worked with prominent organizations such as Ab Science and Université Paris Cité. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Thiago has had the opportunity to work alongside esteemed colleagues, including Alain Moussy and Jean-Pierre Kinet. These collaborations have further enriched his research and development efforts in the medical field.

Conclusion

Thiago Trovati Maciel is a distinguished inventor whose work in the treatment of sickle cell disease has the potential to make a significant impact on patient care. His innovative approach and dedication to research exemplify the spirit of invention in the medical community.